|
Emphasys Medical cancels plans for IPO
|
|
|
Posted on
May 13 2008 5:26 AM
by
adeal
|
Emphasys Medical Inc., which developed a medical device to treat emphysema, has canceled its plans for an initial public offering, citing market conditions, according to a Securities and Exchange Commission filing Monday. In September 2007 when Emphasys filed for the IPO, the company estimated that the offering price could total up to $86.3 million. The same month, Emphasys filed for premarket approval of its first product, the Emphasys endobronchial valve.
|
|
No comment found for this blog
|
|